1. Home
  2. MTEX vs NVNO Comparison

MTEX vs NVNO Comparison

Compare MTEX & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTEX
  • NVNO
  • Stock Information
  • Founded
  • MTEX 1993
  • NVNO 1987
  • Country
  • MTEX United States
  • NVNO United States
  • Employees
  • MTEX N/A
  • NVNO N/A
  • Industry
  • MTEX Medicinal Chemicals and Botanical Products
  • NVNO Medical/Dental Instruments
  • Sector
  • MTEX Health Care
  • NVNO Health Care
  • Exchange
  • MTEX Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • MTEX 15.8M
  • NVNO 16.7M
  • IPO Year
  • MTEX 1999
  • NVNO N/A
  • Fundamental
  • Price
  • MTEX $8.60
  • NVNO $0.92
  • Analyst Decision
  • MTEX
  • NVNO
  • Analyst Count
  • MTEX 0
  • NVNO 0
  • Target Price
  • MTEX N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • MTEX 9.6K
  • NVNO 2.4M
  • Earning Date
  • MTEX 11-11-2025
  • NVNO 10-30-2025
  • Dividend Yield
  • MTEX N/A
  • NVNO N/A
  • EPS Growth
  • MTEX N/A
  • NVNO N/A
  • EPS
  • MTEX N/A
  • NVNO N/A
  • Revenue
  • MTEX $112,975,000.00
  • NVNO N/A
  • Revenue This Year
  • MTEX N/A
  • NVNO N/A
  • Revenue Next Year
  • MTEX N/A
  • NVNO N/A
  • P/E Ratio
  • MTEX N/A
  • NVNO N/A
  • Revenue Growth
  • MTEX N/A
  • NVNO N/A
  • 52 Week Low
  • MTEX $7.05
  • NVNO $0.67
  • 52 Week High
  • MTEX $16.49
  • NVNO $5.62
  • Technical
  • Relative Strength Index (RSI)
  • MTEX 49.32
  • NVNO 25.89
  • Support Level
  • MTEX $7.80
  • NVNO $0.67
  • Resistance Level
  • MTEX $9.75
  • NVNO $0.94
  • Average True Range (ATR)
  • MTEX 0.86
  • NVNO 0.06
  • MACD
  • MTEX -0.02
  • NVNO 0.14
  • Stochastic Oscillator
  • MTEX 30.19
  • NVNO 91.44

About MTEX Mannatech Incorporated

Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a late clinical-stage medical device company focused on advancing bioprosthetic (tissue-based) solutions to improve the standard of care for treating venous disease. The company's product, VenoValve, is a surgical replacement venous valve that is currently being evaluated in a U.S. pivotal study. The company is also developing a second product called enVVe, which is a non-surgical, transcatheter-based replacement venous valve. Both the products are designed to act as one-way valves to help assist in propelling blood up the veins of the leg, and back to the heart and lungs. The company has determined that it currently operates in a single segment, Medical Device development, located in a single geographic location, the United States.

Share on Social Networks: